CXCR5 and B-cell chronic lymphocytic leukemia: Since it is established that T cells in CLL patients acquire several phenotypic and functional alterations [14, 15, 16], we analyzed CXCR5+PD‐1+ CD8 T cells across these malignancies to determine whether there is a relation between these cells and the response to PD‐1 ICB.